READ

Popping pills in space

And you think you've had a bad head cold ...
Thomas Crow
Thomas Crow
Freelance science writer
Popping pills in space

Getting sick in space is no joke. You’re stuck, surrounded by the most advanced equipment in the world, most of which is useless if you need a medicine you didn’t think to bring.

Even taking a pill has its problems as the constant radiation breaks them down.

Professor Volker Hessel is a researcher at the University of Adelaide who has sent medicine up to the International Space Station (ISS) to test how pills survive in space.

The plan is to understand how we can make space drugs that can last the 3-year trip to Mars.

In space, no one can hear you sneeze

Astronauts are extremely fit for a reason. Space is incredibly stressful to human bodies. Microgravity means astronauts lose 1–2% of their bone mass each month.

Radiation also changes astronaut DNA.

Medicine has an important role on the ISS. It saved an astronaut from a serious blood clot in 2016.

On the Apollo 7 mission, Wally Schirra’s head cold meant every decongestant and tissue on board was used.

It was such a disaster it led to a crew mutiny, which banned the team from ever entering space again.

Three NASA astronauts wearing white space suits pose for the camera - they are the crew members of the Apollo 7 mission
View Larger

The Apollo 7 crew with Wally Schirra (right) prior to the space sniffle disaster

Image credit: NASA
The Apollo 7 crew with Wally Schirra (right) prior to the space sniffle disaster

Take your protein pill and put your helmet on

Volker’s team sent up two medicines: ibuprofen and vitamin C.

“No medicine survives in space longer than 1 year. Many don’t last that long,” Volker says.

This is a big problem for future Mars trips. Astronauts would run out of medicine a third of the way there.

Once Volker understands how these medicines are affected by radiation, he wants to find ways to make them last longer or even make them in space.

Ibuprofen is one of the most commonly used drugs in the world. It’s a market that makes US$294.4 million per year with millions of tablets being manufactured.

It’s a great starting point. It’s versatile, easy to make and is already the subject of decades of research.

“There’s a lot of research on radiation’s effects on ibuprofen because we try to decompose it to reduce its environmental impact here on Earth. We know its lasting effects in water contamination, which is important when you’re reusing water in space,” Volker Hessel says.

Orbital decay

The main goal of Volker’s research is to see what effects space has on ibuprofen tablets. There are two parts to the mission, with tablets sent up to the ISS last year and early this year.

View from above the International Space Station with the Earth floating below
View Larger

Not much room to move on the ISS!

Image credit: NASA
Not much room to move on the ISS!

One set of tablets is inside the ISS while one is outside the station, exposed to solar radiation.

Both samples will return to Earth for Volker to test their radiation decay.

“Because of the cost of space, we could only bring 60 tablets. So we’re continuing experiments on Earth, trying to replicate space conditions.”

Space refineries

On Earth, ibuprofen is made by decomposing and refining petroleum to produce two different chemical molecules: benzene and propylene.

When they’re heated in acidic conditions, they combine to make ibuprofen.

The catch is that petroleum on Earth mostly comes from fossilised life, trapped beneath the Earth millions of years ago.

But there’s little to no space petroleum. This means we need to rethink how we make medicine.

“Around half the tablet’s contents are organic cellulose: plant fibre. We removed that, which reduces the tablet effectiveness but means they could be made in space,” Volker says.

So future research will look at how we can make these everyday medicines when we don’t have access to Earth’s vast resources.

Thomas Crow
About the author
Thomas Crow
Thomas Crow is an Australian science writer. He has a background in professional writing, biochemistry and genetics. He writes for Australian and New Zealand research institutes and publications like Crikey. He's a horror and gothic fantasy fan. He thinks of himself as a gardener but scores of dead plants beg to differ.
View articles
Thomas Crow is an Australian science writer. He has a background in professional writing, biochemistry and genetics. He writes for Australian and New Zealand research institutes and publications like Crikey. He's a horror and gothic fantasy fan. He thinks of himself as a gardener but scores of dead plants beg to differ.
View articles

NEXT ARTICLE

We've got chemistry, let's take it to the next level!

Get the latest WA science news delivered to your inbox, every fortnight.

This field is for validation purposes and should be left unchanged.

Republish

Creative Commons Logo

Republishing our content

We want our stories to be shared and seen by as many people as possible.

Therefore, unless it says otherwise, copyright on the stories on Particle belongs to Scitech and they are published under a Creative Commons Attribution-NoDerivatives 4.0 International License.

This allows you to republish our articles online or in print for free. You just need to credit us and link to us, and you can’t edit our material or sell it separately.

Using the ‘republish’ button on our website is the easiest way to meet our guidelines.

Guidelines

You cannot edit the article.

When republishing, you have to credit our authors, ideally in the byline. You have to credit Particle with a link back to the original publication on Particle.

If you’re republishing online, you must use our pageview counter, link to us and include links from our story. Our page view counter is a small pixel-ping (invisible to the eye) that allows us to know when our content is republished. It’s a condition of our guidelines that you include our counter. If you use the ‘republish’ then you’ll capture our page counter.

If you’re republishing in print, please email us to let us so we know about it (we get very proud to see our work republished) and you must include the Particle logo next to the credits. Download logo here.

If you wish to republish all our stories, please contact us directly to discuss this opportunity.

Images

Most of the images used on Particle are copyright of the photographer who made them.

It is your responsibility to confirm that you’re licensed to republish images in our articles.

Video

All Particle videos can be accessed through YouTube under the Standard YouTube Licence.

The Standard YouTube licence

  1. This licence is ‘All Rights Reserved’, granting provisions for YouTube to display the content, and YouTube’s visitors to stream the content. This means that the content may be streamed from YouTube but specifically forbids downloading, adaptation, and redistribution, except where otherwise licensed. When uploading your content to YouTube it will automatically use the Standard YouTube licence. You can check this by clicking on Advanced Settings and looking at the dropdown box ‘License and rights ownership’.
  2. When a user is uploading a video he has license options that he can choose from. The first option is “standard YouTube License” which means that you grant the broadcasting rights to YouTube. This essentially means that your video can only be accessed from YouTube for watching purpose and cannot be reproduced or distributed in any other form without your consent.

Contact

For more information about using our content, email us: particle@scitech.org.au

Copy this HTML into your CMS
Press Ctrl+C to copy